Patents by Inventor Alex Azhayev

Alex Azhayev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8779194
    Abstract: The present invention relates to carbamoylation of amines, mercaptanes, thiophenols and phenols employing organic azides. More specifically, the invention relates to a method for generating urea derivatives, thiocarbamate derivatives and carbamate derivatives, and is based on the intermediate formation of isocyanate, starting from an organic azide. The reaction as described is useful in applications for modified nucleoside synthesis, oligonucleotide synthesis, as well as modification, labeling and conjugation of polymers and biomolecules.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: July 15, 2014
    Assignee: Metkinen Chemistry Oy
    Inventors: Andrey Yagodkin, Alex Azhayev
  • Patent number: 7491817
    Abstract: Universal supports for oligonucleotide synthesis include a support material represented by the following formula: In this formula, substituent A is selected from H, alkyl, aryl, or a polymeric or silica base material; substituent B is selected from acyl, aroyl, or a polymeric or silica base material; and substituent C is selected from a dimethoxytrityl group or a protecting group removable under acidic or neutral conditions. For the supports, one of substituents A or B constitutes the polymeric or silica base material. In use, an oligonucleotide is attached to the support at substituent C.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: February 17, 2009
    Assignee: Glen Research Corporation
    Inventors: Alex Azhayev, Maxim Antopolskii
  • Publication number: 20070065922
    Abstract: Purine N9-?-D-nucleosides containing 3-amino-3-deoxy-?-D-ribofaranose, 3-amino-2,3-dideoxy-?-D-ribofuranose, and 2-amino-2-deoxy-?-D-ribofuranose as sugar moieties are synthesized by biocatalytic transglycosylation of purine bases and the respective 3?-amino-3?-deoxyuridine, 3?-amino-3?-deoxythymidine and 2?-amino-2?-deoxyuridine as donors of the carbohydrate moiety, and the cells of Escherichia coli as a biocatalyst or glutaraldehyde (GA) treated cells of Escherichia coli as a biocatalyst or a mixture of thymidine (uridine) phosphorylase and purine nucleoside phosphorylase.
    Type: Application
    Filed: November 29, 2005
    Publication date: March 22, 2007
    Applicant: Metkinen Oy
    Inventors: Vladimir Barai, Ludmilla Eroshevskaya, Igor Mikhailopulo, Alex Azhayev, Seppo Lapinjoki
  • Publication number: 20050250116
    Abstract: Universal supports for oligonucleotide synthesis include a support material represented by the following formula: In this formula, substituent A is selected from H, alkyl, aryl, or a polymeric or silica base material; substituent B is selected from acyl, aroyl, or a polymeric or silica base material; and substituent C is selected from a dimethoxytrityl group or a protecting group removable under acidic or neutral conditions. For the supports, one of substituents A or B constitutes the polymeric or silica base material. In use, an oligonucleotide is attached to the support at substituent C.
    Type: Application
    Filed: May 24, 2004
    Publication date: November 10, 2005
    Applicant: Glen Research Corporation
    Inventors: Alex Azhayev, Maxim Antopolskii
  • Patent number: 6770754
    Abstract: Universal supports for oligonucleotide synthesis include a support material represented by the following formula: In this formula, substituent A is selected from H, alkyl, aryl, or a polymeric or silica base material; substituent B is selected from acyl, aroyl, or a polymeric or silica base material; and substituent C is selected from a dimethoxytrityl group or a protecting group removable under acidic or neutral conditions. For the supports, one of substituents A or B constitutes the polymeric or silica base material. In use, an oligonucleotide is attached to the support at substituent C.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: August 3, 2004
    Assignee: Glen Research Coporation
    Inventors: Alex Azhayev, Maxim Antopolskii
  • Publication number: 20040054161
    Abstract: A support for peptide-oligonucleotide conjugate synthesis includes an article of manufacture according to the formula: 1
    Type: Application
    Filed: September 13, 2002
    Publication date: March 18, 2004
    Applicant: Glen Research Corporation
    Inventors: Maxim Antopolskii, Elena Azhayeva, Alex Azhayev
  • Publication number: 20030148928
    Abstract: This invention features conjugates, compositions, methods of synthesis, and applications thereof, including galactose, galactosamine, N-acetyl galactosamine, PEG, phospholipid, and human serum albumin (HSA) derived conjugates of nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.
    Type: Application
    Filed: July 22, 2002
    Publication date: August 7, 2003
    Inventors: Leonid Beigelman, Alex Azhayev, Elena Azhayeva, Maxim Antopolsky
  • Publication number: 20020137855
    Abstract: Universal supports for oligonucleotide synthesis include a support material represented by the following formula: 1
    Type: Application
    Filed: November 29, 2001
    Publication date: September 26, 2002
    Applicant: Glen Research Corporation
    Inventors: Alex Azhayev, Maxim Antopolskii
  • Patent number: 5959090
    Abstract: Phosphoramidite building blocks according to the following formula 1 are used for phosphorylating oligonucleotides, preferably at the 5'- or 3'-terminus. The building blocks include phosphoramidite compounds according to formula 1: ##STR1## wherein DMTr is a 4,4'-dimethoxytrityl group; R.sub.1 is an electron withdrawing group; R.sub.2 is an electron withdrawing group which may be the same or different from the R.sub.1 group; R.sub.3 is an alkyl group; and R.sub.4 is an alkyl group which may be the same or different from the R.sub.3 group. Preferred electron withdrawing groups include --CO.sub.2 Et groups, --CO.sub.2 Me groups, --CN groups, --CON(Me).sub.2 groups, and --CONHMe groups, wherein Et represents an ethyl group and Me represents a methyl group. One preferred alkyl group is an isopropyl group.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: September 28, 1999
    Assignee: Glen Research Corporation
    Inventors: Andrei Guzaev, Alex Azhayev, Harri Lonnberg